Published in Phys Med Biol on August 12, 2011
DCE-MRI analysis methods for predicting the response of breast cancer to neoadjuvant chemotherapy: pilot study findings. Magn Reson Med (2013) 1.19
Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer. Invest Radiol (2015) 0.99
Parameterizing the Logistic Model of Tumor Growth by DW-MRI and DCE-MRI Data to Predict Treatment Response and Changes in Breast Cancer Cellularity during Neoadjuvant Chemotherapy. Transl Oncol (2013) 0.97
Practical dynamic contrast enhanced MRI in small animal models of cancer: data acquisition, data analysis, and interpretation. Pharmaceutics (2012) 0.94
Longitudinal, intermodality registration of quantitative breast PET and MRI data acquired before and during neoadjuvant chemotherapy: preliminary results. Med Phys (2014) 0.90
The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge. Tomography (2016) 0.89
A comparison of two methods for estimating DCE-MRI parameters via individual and cohort based AIFs in prostate cancer: a step towards practical implementation. Magn Reson Imaging (2014) 0.86
Tumor Vascularity in Renal Masses: Correlation of Arterial Spin-Labeled and Dynamic Contrast-Enhanced Magnetic Resonance Imaging Assessments. Clin Genitourin Cancer (2015) 0.84
Analyzing Spatial Heterogeneity in DCE- and DW-MRI Parametric Maps to Optimize Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer. Transl Oncol (2014) 0.83
DCEMRI.jl: a fast, validated, open source toolkit for dynamic contrast enhanced MRI analysis. PeerJ (2015) 0.81
Quantitative pharmacokinetic analysis of prostate cancer DCE-MRI at 3T: comparison of two arterial input functions on cancer detection with digitized whole mount histopathological validation. Magn Reson Imaging (2015) 0.81
Validation of a T1 and T2* leakage correction method based on multiecho dynamic susceptibility contrast MRI using MION as a reference standard. Magn Reson Med (2015) 0.81
Dynamic Contrast-enhanced MR Imaging in Renal Cell Carcinoma: Reproducibility of Histogram Analysis on Pharmacokinetic Parameters. Sci Rep (2016) 0.79
Reproducibility of Dynamic Contrast-Enhanced MRI in Renal Cell Carcinoma: A Prospective Analysis on Intra- and Interobserver and Scan-Rescan Performance of Pharmacokinetic Parameters. Medicine (Baltimore) (2015) 0.79
Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer clinical trials: potential roles and possible pitfalls. Transl Oncol (2014) 0.78
Assessment of repeatability and treatment response in early phase clinical trials using DCE-MRI: comparison of parametric analysis using MR- and CT-derived arterial input functions. Eur Radiol (2015) 0.78
Techniques and applications of dynamic contrast enhanced magnetic resonance imaging in cancer. Conf Proc IEEE Eng Med Biol Soc (2014) 0.76
DCE-MRI Perfusion and Permeability Parameters as predictors of tumor response to CCRT in Patients with locally advanced NSCLC. Sci Rep (2016) 0.75
Assessment of a simplified spin and gradient echo (sSAGE) approach for human brain tumor perfusion imaging. Magn Reson Imaging (2016) 0.75
Assessment of pharmacokinetics for microvessel proliferation by DCE-MRI for early detection of physeal bone bridge formation in an animal model. MAGMA (2017) 0.75
A concordance correlation coefficient to evaluate reproducibility. Biometrics (1989) 28.24
Nonrigid registration using free-form deformations: application to breast MR images. IEEE Trans Med Imaging (1999) 21.56
The adaptive bases algorithm for intensity-based nonrigid image registration. IEEE Trans Med Imaging (2003) 6.12
Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med (2006) 3.63
Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A (2005) 3.15
Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging (2003) 2.77
Determination of the MRI contrast agent concentration time course in vivo following bolus injection: effect of equilibrium transcytolemmal water exchange. Magn Reson Med (2000) 2.75
Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging (2006) 2.69
Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and Examples. Curr Med Imaging Rev (2009) 2.52
Variation of the relaxographic "shutter-speed" for transcytolemmal water exchange affects the CR bolus-tracking curve shape. Magn Reson Med (2003) 2.23
Temporal sampling requirements for the tracer kinetics modeling of breast disease. Magn Reson Imaging (1998) 2.11
Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer. Clin Cancer Res (2008) 1.95
Assessing changes in tumour vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed (2002) 1.80
Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology. NMR Biomed (2005) 1.65
Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat (2004) 1.62
Automatic selection of arterial input function using cluster analysis. Magn Reson Med (2006) 1.50
Comparison of model-based arterial input functions for dynamic contrast-enhanced MRI in tumor bearing rats. Magn Reson Med (2009) 1.30
Feasibility of using limited-population-based arterial input function for pharmacokinetic modeling of osteosarcoma dynamic contrast-enhanced MRI data. Magn Reson Med (2008) 1.30
Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors. J Magn Reson Imaging (2001) 1.25
Investigation and optimization of parameter accuracy in dynamic contrast-enhanced MRI. J Magn Reson Imaging (2008) 1.23
Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study. Radiology (2003) 1.19
Breast image registration techniques: a survey. Med Biol Eng Comput (2006) 1.15
Dynamic contrast-enhanced MRI of vascular changes induced by the VEGF-signalling inhibitor ZD4190 in human tumour xenografts. Magn Reson Imaging (2003) 1.05
3T MRI in paediatrics: challenges and clinical applications. Eur J Radiol (2008) 1.01
Breast MR imaging at 3T. Magn Reson Imaging Clin N Am (2007) 0.94
Pharmacokinetic mapping for lesion classification in dynamic breast MRI. J Magn Reson Imaging (2010) 0.93
Sensitivity of quantitative metrics derived from DCE MRI and a pharmacokinetic model to image quality and acquisition parameters. Acad Radiol (2010) 0.93
Automatic determination of arterial input function for dynamic contrast enhanced MRI in tumor assessment. Med Image Comput Comput Assist Interv (2008) 0.88
Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients. Eur J Radiol (2006) 0.87
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest (2011) 14.22
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E). Nature (2011) 10.77
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell (2004) 8.78
Detection of functional connectivity using temporal correlations in MR images. Hum Brain Mapp (2002) 7.75
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol (2010) 7.08
Brain connectivity related to working memory performance. J Neurosci (2006) 5.69
Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev (2011) 5.64
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer. N Engl J Med (2015) 5.57
Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell (2003) 5.36
Minimization of region-scalable fitting energy for image segmentation. IEEE Trans Image Process (2008) 4.23
Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet (2013) 3.83
Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates. Development (2005) 3.57
Disruption of posterior brain systems for reading in children with developmental dyslexia. Biol Psychiatry (2002) 3.41
Tumour biology: herceptin acts as an anti-angiogenic cocktail. Nature (2002) 3.40
Inhibition of SIRT1 catalytic activity increases p53 acetylation but does not alter cell survival following DNA damage. Mol Cell Biol (2006) 3.37
Simple decision rules for classifying human cancers from gene expression profiles. Bioinformatics (2005) 3.24
Breast cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2009) 3.17
Regional brain volumes and their later neurodevelopmental correlates in term and preterm infants. Pediatrics (2003) 3.09
Assessing functional connectivity in the human brain by fMRI. Magn Reson Imaging (2007) 3.03
Efficacy and safety of sitagliptin in patients with type 2 diabetes and ESRD receiving dialysis: a 54-week randomized trial. Am J Kidney Dis (2013) 2.89
Induction of angiogenesis in a mouse model using engineered transcription factors. Nat Med (2002) 2.81
Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial results. Magn Reson Imaging (2006) 2.69
A level set method for image segmentation in the presence of intensity inhomogeneities with application to MRI. IEEE Trans Image Process (2011) 2.68
Targeting placental growth factor/neuropilin 1 pathway inhibits growth and spread of medulloblastoma. Cell (2013) 2.64
Separable neural components in the processing of black and white faces. Psychol Sci (2004) 2.59
Quantitative pharmacokinetic analysis of DCE-MRI data without an arterial input function: a reference region model. Magn Reson Imaging (2005) 2.54
Dynamic Contrast Enhanced Magnetic Resonance Imaging in Oncology: Theory, Data Acquisition, Analysis, and Examples. Curr Med Imaging Rev (2009) 2.52
Multiscale pattern analysis of orientation-selective activity in the primary visual cortex. J Neurosci (2010) 2.51
Development of left occipitotemporal systems for skilled reading in children after a phonologically- based intervention. Biol Psychiatry (2004) 2.48
Changes in functional connectivity of human MT/V5 with visual motion input. Neuroreport (2004) 2.44
CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies? Clin Cancer Res (2011) 2.39
A functional magnetic resonance imaging study of bipolar disorder: state- and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry (2003) 2.36
The neural correlates of third-party punishment. Neuron (2008) 2.33
Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation. Biol Psychiatry (2003) 2.31
Undetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma. Ann Surg Oncol (2004) 2.27
The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature (2004) 2.22
Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials. PLoS One (2012) 2.21
Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder. Arch Gen Psychiatry (2003) 2.15
Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. J Clin Oncol (2008) 2.15
miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs. Plant Mol Biol (2012) 2.14
BSMART: a Matlab/C toolbox for analysis of multichannel neural time series. Neural Netw (2008) 2.14
Paracrine regulation of angiogenesis and adipocyte differentiation during in vivo adipogenesis. Circ Res (2003) 2.12
Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst (2003) 2.11
Short preoperative treatment with erlotinib inhibits tumor cell proliferation in hormone receptor-positive breast cancers. J Clin Oncol (2008) 2.10
Classification and quantification of neuronal fiber pathways using diffusion tensor MRI. Magn Reson Med (2003) 2.08
Connectivity-behavior analysis reveals that functional connectivity between left BA39 and Broca's area varies with reading ability. Neuroimage (2006) 2.06
An FMRI Stroop task study of ventromedial prefrontal cortical function in pathological gamblers. Am J Psychiatry (2003) 2.05
Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer. Clin Cancer Res (2011) 2.03
Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium. PLoS Genet (2010) 1.98
The relationship between delirium duration, white matter integrity, and cognitive impairment in intensive care unit survivors as determined by diffusion tensor imaging: the VISIONS prospective cohort magnetic resonance imaging study*. Crit Care Med (2012) 1.97
The association between brain volumes, delirium duration, and cognitive outcomes in intensive care unit survivors: the VISIONS cohort magnetic resonance imaging study*. Crit Care Med (2012) 1.96
GPR56 regulates pial basement membrane integrity and cortical lamination. J Neurosci (2008) 1.93
Oscillating gradient measurements of water diffusion in normal and globally ischemic rat brain. Magn Reson Med (2003) 1.88
The relationship of anatomical and functional connectivity to resting-state connectivity in primate somatosensory cortex. Neuron (2013) 1.87
Resistance to Trastuzumab in Breast Cancer. Clin Cancer Res (2009) 1.86
Neural systems for compensation and persistence: young adult outcome of childhood reading disability. Biol Psychiatry (2003) 1.84
Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006. J Clin Oncol (2013) 1.81
An event-related functional MRI study comparing interference effects in the Simon and Stroop tasks. Brain Res Cogn Brain Res (2002) 1.79
Breast cancer, version 3.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw (2013) 1.79
Validation of diffusion tensor MRI-based muscle fiber tracking. Magn Reson Med (2002) 1.71
Functional connectivity between task-positive and task-negative brain areas and its relation to working memory performance. Magn Reson Imaging (2010) 1.71
Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. Ann Surg Oncol (2003) 1.70
Frontostriatal abnormalities in adolescents with bipolar disorder: preliminary observations from functional MRI. Am J Psychiatry (2003) 1.70
Preliminary evidence for medication effects on functional abnormalities in the amygdala and anterior cingulate in bipolar disorder. Psychopharmacology (Berl) (2005) 1.67
Molecular imaging of therapeutic response to epidermal growth factor receptor blockade in colorectal cancer. Clin Cancer Res (2008) 1.66
Accuracy of intraoperative gross examination of surgical margin status in women undergoing partial mastectomy for breast malignancy. Am Surg (2005) 1.65
Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents. Breast Cancer Res Treat (2010) 1.65
Efficacy and safety of sitagliptin in the treatment of patients with type 2 diabetes in China, India, and Korea. Diabetes Res Clin Pract (2008) 1.65
NO mediates mural cell recruitment and vessel morphogenesis in murine melanomas and tissue-engineered blood vessels. J Clin Invest (2005) 1.65
Simultaneous measurement of arterial input function and tumor pharmacokinetics in mice by dynamic contrast enhanced imaging: effects of transcytolemmal water exchange. Magn Reson Med (2004) 1.65
New strategies for triple-negative breast cancer--deciphering the heterogeneity. Clin Cancer Res (2014) 1.65
Gambling urges in pathological gambling: a functional magnetic resonance imaging study. Arch Gen Psychiatry (2003) 1.63
Breast cancer version 3.2014. J Natl Compr Canc Netw (2014) 1.63
Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol (2009) 1.62
Quantitative imaging of magnetization transfer using an inversion recovery sequence. Magn Reson Med (2003) 1.62
Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis. Cancer Res (2006) 1.60
Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese. Clin Endocrinol (Oxf) (2011) 1.59
Breast Cancer Version 2.2015. J Natl Compr Canc Netw (2015) 1.59
Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg (2003) 1.58
Monitoring the inflammatory response to infection through the integration of MALDI IMS and MRI. Cell Host Microbe (2012) 1.58
Integrating spatially resolved three-dimensional MALDI IMS with in vivo magnetic resonance imaging. Nat Methods (2007) 1.58
Perivascular nitric oxide gradients normalize tumor vasculature. Nat Med (2008) 1.56
Statins, autophagy and cancer metastasis. Int J Biochem Cell Biol (2012) 1.56
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance. Nat Med (2012) 1.55
TGF-β blockade improves the distribution and efficacy of therapeutics in breast carcinoma by normalizing the tumor stroma. Proc Natl Acad Sci U S A (2012) 1.51
A practical guide to robust detection of GABA in human brain by J-difference spectroscopy at 3 T using a standard volume coil. Magn Reson Imaging (2007) 1.49
Comparison of a reference region model with direct measurement of an AIF in the analysis of DCE-MRI data. Magn Reson Med (2007) 1.49
Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biol (2007) 1.48
fMRI activation of the fusiform gyrus and amygdala to cartoon characters but not to faces in a boy with autism. Neuropsychologia (2005) 1.48
Shutter-speed analysis of contrast reagent bolus-tracking data: Preliminary observations in benign and malignant breast disease. Magn Reson Med (2005) 1.48
Repeatability of a reference region model for analysis of murine DCE-MRI data at 7T. J Magn Reson Imaging (2006) 1.47
Genetically encoded fluorescent sensors for intracellular NADH detection. Cell Metab (2011) 1.47
Reduction of noise in diffusion tensor images using anisotropic smoothing. Magn Reson Med (2005) 1.47